首页> 外文会议>International Conference on Machinery, Materials and Computing Technology >Synthesis of Tert-butyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1 H-pyrazol-1-yl)piperidine-1-carboxylate
【24h】

Synthesis of Tert-butyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1 H-pyrazol-1-yl)piperidine-1-carboxylate

机译:叔丁基-4-(4-(4,4,4,4,5,5-四甲基-1,3,2-二氧化物-2-基)-1H-Pyrazol-1-Y1)哌啶-1-羧酸叔丁酯的合成

获取原文

摘要

Tert-butyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate (1) is an important intermediate in many biologically active compounds such as crizotinib. In this work, compound (1) was synthesized through three steps, using tert-butyl-4-hydroxypiperdine-1-carboxylate as starting material. And the structures of tert-butyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxy late was confirmed by MS and ~1HNMR spectrum. The total yield of the three steps was 49.9%.
机译:叔丁基-4-(4-(4,4,4,4,4,4,4,4,4,5,5-四甲基-1,3,2-二氧化物-2-基)-1H-吡唑-1-基)哌啶-1-羧酸甲酯(1)是许多生物活性化合物如屈服in的重要中间体。在该作品中,使用叔丁基-4-羟基哌啶-1-羧酸盐作为原料,通过三个步骤合成化合物(1)。和叔丁基-4-(4-(4,4,4,4,4,4,4,4,4,4,5,5-四甲基-1,3,2-二氧化物-2-基)-1H-吡唑-1-基的结构的结构哌啶-1-羧基已晚被MS和〜1HNMR谱证实。三步的总产量为49.9%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号